Saizen 60 IU - Merck

Human Growth Hormone therapy entered medicine with a crude and risky process—extracting pituitary tissue from cadavers, which carried the threat of infection. This method, in use from 1958 until 1985, was stopped after several users contracted Creutzfeldt-Jakob disease. The same year, the biotechnology company Genentech introduced somatrem, the first genetically engineered HGH. Though slightly different from the body’s natural version, it proved effective. It was soon replaced by somatropin, the exact-match form now used globally.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Saizen 60 IU by Merck, consult with your doctor or healthcare professional.